InVivoMAb anti-mouse LAG-3
BE0174
ApplicationsFlow Cytometry, Western Blot, Neutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse LAG-3
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Western Blot, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDC9B7W
- Concentration4-11 mg/ml
- Estimated Purity≥95% , Determined by SDS-PAGE
- HostRat
- IsotypeIgG1
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC41116161
References
- LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis. Bauche D et al., 2018 Aug 21, ImmunityRead this paper
- Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Rouhani SJ et al., 2015 Apr 10, Nat CommunRead this paper
- Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo. Durham NM et al., 2014, PLoS OneRead this paper
- Programmed death-1 impairs secondary effector lung CD8+ T cells during respiratory virus reinfection. Erickson JJ et al., 2014 Nov 15, J ImmunolRead this paper
- Blockade of LFA-1 augments in vitro differentiation of antigen-induced Foxp3+ Treg cells. Verhagen J et al., 2014 Dec 1, J Immunol MethodsRead this paper
- Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. McGray AJ et al., 2014 Jan, Mol TherRead this paper
- Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma. Goding SR et al., 2013 May 1, J ImmunolRead this paper
